These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 8782850)
1. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Bostom AG; Shemin D; Lapane KL; Nadeau MR; Sutherland P; Chan J; Rozen R; Yoburn D; Jacques PF; Selhub J; Rosenberg IH Atherosclerosis; 1996 Jun; 123(1-2):193-202. PubMed ID: 8782850 [TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients. Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347 [TBL] [Abstract][Full Text] [Related]
3. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Bostom AG; Shemin D; Verhoef P; Nadeau MR; Jacques PF; Selhub J; Dworkin L; Rosenberg IH Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2554-8. PubMed ID: 9409227 [TBL] [Abstract][Full Text] [Related]
4. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis. Verhoeff BJ; Trip MD; Prins MH; Kastelein JJ; Reitsma PH Atherosclerosis; 1998 Nov; 141(1):161-6. PubMed ID: 9863549 [TBL] [Abstract][Full Text] [Related]
5. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients. Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946 [TBL] [Abstract][Full Text] [Related]
6. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease. de Jong SC; Stehouwer CD; van den Berg M; Kostense PJ; Alders D; Jakobs C; Pals G; Rauwerda JA Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1316-24. PubMed ID: 10323785 [TBL] [Abstract][Full Text] [Related]
7. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Födinger M; Mannhalter C; Wölfl G; Pabinger I; Müller E; Schmid R; Hörl WH; Sunder-Plassmann G Kidney Int; 1997 Aug; 52(2):517-23. PubMed ID: 9264011 [TBL] [Abstract][Full Text] [Related]
8. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation]. Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000 [TBL] [Abstract][Full Text] [Related]
13. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay. Herrmann W; Obeid R; Schorr H; Zarzour W; Geisel J Clin Chem Lab Med; 2003 Apr; 41(4):547-53. PubMed ID: 12747601 [TBL] [Abstract][Full Text] [Related]
14. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318 [TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Girelli D; Friso S; Trabetti E; Olivieri O; Russo C; Pessotto R; Faccini G; Pignatti PF; Mazzucco A; Corrocher R Blood; 1998 Jun; 91(11):4158-63. PubMed ID: 9596662 [TBL] [Abstract][Full Text] [Related]
16. What is the meaning of homocysteine in patients on dialysis? Silva de Almeida CC; Guerra DC; Vannucchi MT; Geleilete TJ; Vannucchi H; Chiarello PG J Ren Nutr; 2011 Sep; 21(5):394-400. PubMed ID: 21439851 [TBL] [Abstract][Full Text] [Related]
17. The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Verhoef P; Kok FJ; Kluijtmans LA; Blom HJ; Refsum H; Ueland PM; Kruyssen DA Atherosclerosis; 1997 Jul; 132(1):105-13. PubMed ID: 9247365 [TBL] [Abstract][Full Text] [Related]
18. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients. Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Perschl A; Vychytil A; Hörl WH; Sunder-Plassmann G Am J Kidney Dis; 2001 Jul; 38(1):77-84. PubMed ID: 11431185 [TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558 [TBL] [Abstract][Full Text] [Related]
20. Effects of hormone replacement therapy and methylenetetrahydrofolate reductase polymorphism on plasma folate and homocysteine levels in postmenopausal Japanese women. Somekawa Y; Kobayashi K; Tomura S; Aso T; Hamaguchi H Fertil Steril; 2002 Mar; 77(3):481-6. PubMed ID: 11872199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]